Jean-Francois Bussieres
Overview
Explore the profile of Jean-Francois Bussieres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beatrix I, Bonnabry E, Thibault M, Atkinson S, Leroux T, Bussieres J
Noise Health
. 2025 Mar;
27(124):33-40.
PMID: 40029676
Objective: Few data are available regarding noise levels in hospital pharmacies. This study mainly aimed to assess noise levels in different areas and during various activities in the pharmacy department...
2.
Bonnabry E, Lebel D, Atkinson S, Roy H, Piaget I, Bussieres J
Am J Health Syst Pharm
. 2024 Dec;
PMID: 39724187
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are...
3.
Beatrix I, Bonnabry E, Atkinson S, Lebel D, Bussieres J
Ann Pharm Fr
. 2024 Dec;
PMID: 39645190
Context: Drug shortages impact patients from all countries. According to the Pharmaceutical Group of the European Union, most Europe countries reported a worsening of shortages in 2023. Objective: To describe...
4.
Dupre M, Marc M, Bussieres J
Can J Hosp Pharm
. 2024 Oct;
77(4):e3588.
PMID: 39386971
Background: The arms of chairs in outpatient oncology clinics are frequently contaminated with cyclophosphamide. Objective: To evaluate the effectiveness of decontamination scenarios. Methods: This was a descriptive simulation-type study of...
5.
Monnier A, Jacolin C, Atkinson S, Bussieres J
Can J Hosp Pharm
. 2024 Jul;
77(3):e3487.
PMID: 38988876
No abstract available.
6.
Maurin C, Atkinson S, Hamouche L, Bussieres J
Can J Hosp Pharm
. 2024 Apr;
77(2):e3528.
PMID: 38601133
Background: The safety of care provided is based on an analysis of medication incidents and accidents. Objective: The primary objective was to describe medication-related incidents and accidents (I&A) within a...
7.
Maurin C, Atkinson S, Hamouche L, Bussieres J
Can J Hosp Pharm
. 2024 Apr;
77(2):e3497.
PMID: 38601131
Background: Since 2022, it has been mandatory in Québec to report all incidents and accidents (I&As) occurring in health-care facilities. Since 2011, a summary report of these I&As has been...
8.
Marc M, Rambourg P, Bussieres J
Ann Pharm Fr
. 2024 Feb;
82(3):560-574.
PMID: 38367934
Context: To ensure compliance with the legal and normative framework, the professional orders, which supervise the practice of pharmacy have established a professional inspection process. In addition to this process,...
9.
Saint-Vil L, Jean-Baptiste T, Martel-Cote N, Lebel D, Bussieres J
Can J Hosp Pharm
. 2024 Feb;
77(1):e3489.
PMID: 38357301
Background: Since 2019, health care facilities have been required to report serious adverse drug reactions (ADRs) to Health Canada. Objectives: To describe the availability of information required for reporting an...
10.
Jacolin C, Monnier A, Farcy E, Atkinson S, Pelchat V, Duval S, et al.
Arch Pediatr
. 2024 Jan;
31(2):100-105.
PMID: 38262862
Objective: Audits are essential for reviewing and improving the medication-use process. Identifying areas for improvement can limit the risk of errors when preparing and administering drugs. Pediatric centers face specific...